secwatch.observer — SEC 8-K summary
======================================

Issuer:     Revolution Medicines, Inc. (RVMD)
CIK:        0001628171
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0001193125-23-164446
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Revolution Medicines 2023 annual meeting results: directors elected, auditor ratified, say-on-pay approved
--------------------------------------------------------------------------------

- Alexis Borisy re-elected to Class III with 41.5M votes for, 48.0M withheld; Mark Goldsmith and Barbara Weber elected with margins >70M.
- PricewaterhouseCoopers LLP ratified as independent auditor for FY2023 with 94.9M for, 6,594 against.
- Non-binding advisory vote on named executive officer compensation passed with 88.7M for, 0.8M against, 5.3M broker non-votes.
- Only three proposals were voted on; no other items presented at the annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628171/000119312523164446/0001193125-23-164446-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628171/000119312523164446/d463772d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-164446

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer